Eva Bondesson

963 total citations
28 papers, 653 citations indexed

About

Eva Bondesson is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Eva Bondesson has authored 28 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 11 papers in Physiology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Eva Bondesson's work include Inhalation and Respiratory Drug Delivery (14 papers), Asthma and respiratory diseases (10 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers). Eva Bondesson is often cited by papers focused on Inhalation and Respiratory Drug Delivery (14 papers), Asthma and respiratory diseases (10 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers). Eva Bondesson collaborates with scholars based in Sweden, United Kingdom and United States. Eva Bondesson's co-authors include Lars Borgström, Folke Morén, Thomas Bengtsson, Per Wollmer, Anders Bjartell, Lars Edenbrandt, Helén Tuvesson, Örjan Nordle, Lars‐Erik Nilsson and Andrew J. Armstrong and has published in prestigious journals such as Journal of Clinical Oncology, Blood and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Eva Bondesson

28 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Bondesson Sweden 14 566 316 101 67 49 28 653
Anton Drollmann Switzerland 14 828 1.5× 693 2.2× 7 0.1× 28 0.4× 21 0.4× 32 981
Heike Biller Germany 15 434 0.8× 326 1.0× 52 0.5× 61 0.9× 22 0.4× 26 712
K.P. Steed United Kingdom 14 431 0.8× 275 0.9× 5 0.0× 29 0.4× 27 0.6× 17 652
Marco Basile Italy 11 128 0.2× 105 0.3× 48 0.5× 19 0.3× 25 0.5× 38 363
Wouter H. van Geffen Netherlands 14 487 0.9× 113 0.4× 19 0.2× 102 1.5× 108 2.2× 43 687
Amisha Singapuri United Kingdom 16 538 1.0× 583 1.8× 10 0.1× 106 1.6× 10 0.2× 39 827
Ruth Hartley United Kingdom 11 396 0.7× 406 1.3× 46 0.5× 15 0.2× 9 0.2× 22 598
James Kozlowski United States 12 351 0.6× 74 0.2× 57 0.6× 42 0.6× 15 0.3× 23 515
Sherif Gonem United Kingdom 14 468 0.8× 499 1.6× 36 0.4× 30 0.4× 11 0.2× 35 753
Chet Leach United States 15 931 1.6× 690 2.2× 4 0.0× 70 1.0× 3 0.1× 24 1.0k

Countries citing papers authored by Eva Bondesson

Since Specialization
Citations

This map shows the geographic impact of Eva Bondesson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Bondesson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Bondesson more than expected).

Fields of papers citing papers by Eva Bondesson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Bondesson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Bondesson. The network helps show where Eva Bondesson may publish in the future.

Co-authorship network of co-authors of Eva Bondesson

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Bondesson. A scholar is included among the top collaborators of Eva Bondesson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Bondesson. Eva Bondesson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vogl, Dan T., Yulia Nefedova, E. Paul Wileyto, et al.. (2024). Tasquinimod, an S100A9 Inhibitor, in Combination with Ixazomib, Lenalidomide, and Dexamethasone for Relapsed and Refractory Multiple Myeloma. Blood. 144(Supplement 1). 7060–7060. 1 indexed citations
2.
Fleming, John, Joy Conway, Michael J. Bennett, et al.. (2019). Quantitative Assessment of Mucociliary Clearance in Smokers with Mild-to-Moderate Chronic Obstructive Pulmonary Disease and Chronic Bronchitis from Planar Radionuclide Imaging Using the Change in Penetration Index. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 32(4). 175–188. 2 indexed citations
3.
Jones, Robert H., John Aspegrén, Christophe Massard, et al.. (2016). Bone Scan Index and Progression-free Survival Data for Progressive Metastatic Castration-resistant Prostate Cancer Patients Who Received ODM-201 in the ARADES Multicentre Study. European Urology Focus. 2(5). 547–552. 15 indexed citations
4.
Cristinacce, Penny L. Hubbard, Eva Bondesson, Lars H. Nordenmark, et al.. (2015). MR Quantitative Equilibrium Signal Mapping: A Reliable Alternative to CT in the Assessment of Emphysema in Patients with Chronic Obstructive Pulmonary Disease. Radiology. 275(2). 579–588. 13 indexed citations
5.
Parker, Geoff J.M., Caleb Roberts, Giovanni A. Buonaccorsi, et al.. (2014). Feasibility assessment of using oxygen-enhanced magnetic resonance imaging for evaluating the effect of pharmacological treatment in COPD. European Journal of Radiology. 83(11). 2093–2101. 27 indexed citations
6.
Kristiansen, Jesper, John Ektor-Andersen, Eva Bondesson, et al.. (2011). Low heart rate variability is associated with extended pain-related sick leave among employed care-seekers. Journal of Rehabilitation Medicine. 43(11). 976–982. 10 indexed citations
7.
Bondesson, Eva, Lennart Jansson, Thomas Bengtsson, & Per Wollmer. (2009). Exhaled breath condensate—site and mechanisms of formation. Journal of Breath Research. 3(1). 16005–16005. 28 indexed citations
8.
Bathoorn, Erik, Jeroen J.W. Liesker, Dirkje S. Postma, et al.. (2008). Anti-Inflammatory Effects of Combined Budesonide/Formoterol in COPD Exacerbations. COPD Journal of Chronic Obstructive Pulmonary Disease. 5(5). 282–290. 29 indexed citations
9.
Bondesson, Eva, Thomas Bengtsson, Lars‐Erik Nilsson, & Per Wollmer. (2007). Site of deposition and absorption of an inhaled hydrophilic solute. British Journal of Clinical Pharmacology. 63(6). 722–731. 17 indexed citations
10.
Bondesson, Eva, Thomas Bengtsson, Lars‐Erik Nilsson, & Per Wollmer. (2006). Effects of Sodium Taurocholate on the Absorption of Inhaled 99mTc-DTPA. Pharmaceutical Research. 23(9). 2122–2128. 3 indexed citations
11.
Bondesson, Eva, Thomas Bengtsson, Lars Borgström, et al.. (2005). Dose Delivery Late in the Breath Can Increase Dry Powder Aerosol Penetration into the Lungs. Journal of Aerosol Medicine. 18(1). 23–33. 12 indexed citations
12.
Bondesson, Eva, et al.. (2003). Planar gamma scintigraphy—points to consider when quantifying pulmonary dry powder aerosol deposition. International Journal of Pharmaceutics. 258(1-2). 227–240. 13 indexed citations
13.
Bondesson, Eva, et al.. (2003). Planar gamma scintigraphy—points to consider when quantifying pulmonary dry powder aerosol deposition. International Journal of Pharmaceutics. 251(1-2). 33–47. 17 indexed citations
14.
Fishwick, David, Lisa Bradshaw, Richard Beasley, et al.. (2001). Cumulative and Single-dose Design to Assess the Bronchodilator Effects of β2-Agonists in Individuals with Asthma. American Journal of Respiratory and Critical Care Medicine. 163(2). 474–477. 34 indexed citations
15.
Bondesson, Eva, et al.. (2001). An Advanced and Detailed In Vitro Validation Procedure for the Radiolabeling of Carrier-Free Terbutaline Sulphate Dry Powder. Journal of Aerosol Medicine. 14(2). 227–236. 6 indexed citations
16.
Conway, Joy, et al.. (2001). Pulmonary Clearance Rate of Two Chemically Different Forms of Inhaled Pertechnetate. Journal of Aerosol Medicine. 14(2). 209–215. 13 indexed citations
17.
Borgström, Lars, et al.. (1998). Discrepancy between In Vitro and In Vivo Dose Variability for a Pressurized Metered Dose Inhaler and a Dry Powder Inhaler. Journal of Aerosol Medicine. 11(s1). S–59. 10 indexed citations
18.
19.
Lofdahl, CG, L. Andersson, Eva Bondesson, et al.. (1997). Differences in bronchodilating potency of salbutamol in Turbuhaler as compared with a pressurized metered-dose inhaler formulation in patients with reversible airway obstruction. European Respiratory Journal. 10(11). 2474–2478. 40 indexed citations
20.
Borgström, Lars, et al.. (1994). Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjects. European Respiratory Journal. 7(1). 69–73. 236 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anton Drollmann Breakdown of academic impact, for papers by Heike Biller Breakdown of academic impact, for papers by K.P. Steed Breakdown of academic impact, for papers by Marco Basile Breakdown of academic impact, for papers by Wouter H. van Geffen Breakdown of academic impact, for papers by Amisha Singapuri Breakdown of academic impact, for papers by Ruth Hartley Breakdown of academic impact, for papers by James Kozlowski Breakdown of academic impact, for papers by Sherif Gonem Breakdown of academic impact, for papers by Chet Leach
Rankless by CCL
2026